Oscar B. Beltran

Bogota, DC, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic Quality.

Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic Quality.

Journal: Journal of clinical medicine

Published: August 09, 2025

Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma.

Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma.

Journal: Oncotarget

Published: May 19, 2025

Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.

Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 02, 2025

Clinical Characteristics and Outcomes of Adults with Budd-Chiari Syndrome: A Single-Center Experience in Colombia.

Clinical Characteristics and Outcomes of Adults with Budd-Chiari Syndrome: A Single-Center Experience in Colombia.

Journal: Digestive diseases (Basel, Switzerland)

Published: December 20, 2024

Latin American expert opinion letter on the feasibility of systemic therapies in combination with locoregional therapies for hepatocellular carcinoma.

Latin American expert opinion letter on the feasibility of systemic therapies in combination with locoregional therapies for hepatocellular carcinoma.

Journal: Annals of hepatology

Published: November 21, 2024

"Hepatocellular carcinoma surveillance: Current challenges in Latin America".

"Hepatocellular carcinoma surveillance: Current challenges in Latin America".

Journal: Annals of hepatology

Published: September 05, 2024

The leading and key role of hepatologists in the multidisciplinary management of patients with hepatocellular carcinoma.

The leading and key role of hepatologists in the multidisciplinary management of patients with hepatocellular carcinoma.

Journal: Annals of hepatology

Published: March 14, 2023

Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.

Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.

Journal: Annals of hepatology

Published: February 03, 2023

Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort.

Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 28, 2020

Colombian experience in the treatment of hepatitis C with direct-acting antiviral agents.

Colombian experience in the treatment of hepatitis C with direct-acting antiviral agents.

Journal: Medicina

Published: January 30, 2019

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy.

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy.

Journal: Case reports in hepatology

Published: September 21, 2018

Heart rate variability, salivary cortisol and competitive state anxiety responses during pre-competition and pre-training moments.

Heart rate variability, salivary cortisol and competitive state anxiety responses during pre-competition and pre-training moments.

Journal: Biology of sport

Published: February 17, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026